Arda Ural serves as Americas Health Sciences and Wellness Industry Markets Leader for Ernst & Young LLP. In this role, he is in service to the firm’s life sciences and healthcare professionals in North and South America, helping them to solve clients’ most pressing issues at the C-suite level, building a sector community and upholding the principles of One EY. 

Arda also serves as the Market Segment Leader for the US-East Region. He has been the US Sector Leader for EY’s Life Sciences Transactions Advisory Services, Strategy & Operations practice, and Market Segment Leader for East Region Transactions Advisory.

Arda has a proven track record in pharma, biotech and med tech industry with almost 30 years of experience in general management, corporate strategy, marketing, new product development, and M&A including acquisitions, spins, divestitures and mergers.

Prior to joining EY, Arda was a Managing Director at another leading strategy firm, where he led the firm’s Life Sciences M&A Practice for six years. Earlier, Arda worked as a VP of Strategic Marketing and a BU Lead at Becton Dickinson, a leading medical technology company He also served as the SVP Marketing & Sales for a start-up biotechnology company Eyetech later acquired by Astellas.

Arda started his career with Pfizer in Istanbul and subsequently relocated to New York where he held leadership roles for ten years in product commercialization and new product development, such as having launched Viagra worldwide and lead the Celebrex US business.

He is a frequent speaker at industry conferences and has over 50 publications concerning life sciences industry.